Physician profile
Jonathan A Waxman
NPI 1386063824
$6,988.79
in general payments reported to CMS, 2019-2025
26 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 80% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $41.42 · 2021: $91.36 · 2022: $921 · 2023: $2,778 · 2024: $1,365 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,975 · Travel and Lodging: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,975.20 |
| Travel and Lodging | $1,217.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,686.90 | 2019-2025 | Scopis Ent, Clarifix Cryotherapy Device, Xpress Ent Dilation System |
| Inspire Medical Systems, INC. | $1,511.43 | 2019-2025 | Inspire |
| Ethicon INC. | $707.00 | 2021-2024 | Monarch Platform |
| Medtronic, INC. | $571.54 | 2023-2025 | Propel |
| Glaxosmithkline, LLC. | $359.46 | 2023-2025 | Nucala |
| Integra Lifesciences Corporation | $339.13 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Hologic Sales and Service, LLC | $325.70 | 2023-2025 | Coolseal Generator |
| Intersect Ent, INC. | $286.25 | 2019 | |
| Neurent Medical Limited | $206.10 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Acera Surgical, INC. | $194.86 | 2023-2025 | Restrata Wound Matrix |
| Genzyme Corporation | $127.14 | 2024-2025 | |
| Medtronic USA, INC. | $124.94 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $85.42 | 2022-2025 | Dupixent |
| Cochlear Americas | $68.93 | 2019-2022 | |
| Abbvie INC. | $63.59 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $52.67 | 2025 | |
| Ets Wound Care LLC | $50.31 | 2025 | Mirragen Advanced Wound Matrix |
| Merck Sharp & Dohme LLC | $48.44 | 2023-2025 | Keytruda |
| Zimmer Biomet Holdings, INC. | $41.42 | 2020 | |
| Mimedx Group, INC. | $39.64 | 2025 | |
| Boston Scientific Corporation | $21.10 | 2024 | |
| Axsome Therapeutics, INC. | $20.04 | 2024 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $17.71 | 2025 | Eohilia |
| Hikma Pharmaceuticals USA | $16.35 | 2024 | Ryaltris |
| Aerin Medical INC. | $15.20 | 2022 | |
| Kls-Martin L.P. | $7.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Waxman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.